Pegylated interferon (peg-IFN) and ribavirin (RBV) are effective in eradicating the hepatitis C virus in more than half of patients. However, anemia arising from RBV-induced hemolysis can prompt dose reductions and lower sustained virologic response (SVR) rates. In early clinical trials, Viramidine
Subjective impressions of a non-naïve Unix and c beginner
✍ Scribed by Karl Farrell
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 299 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0141-9331
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In Southernmost Brazil HIV‐1 subtypes B, C, and CRF31\_BC co‐circulates and, since 1996 with the implementation of free access to highly active antiretroviral treatment (HAART), this epidemic is under a quite characteristic selective pressure. The profile of mutations and polymorphisms
## Abstract HIV is known to affect the epidemiology, transmission, pathogenesis and natural history of HCV infection whilst studies on the effects of HCV on HIV have shown conflicting results and are confounded by the influence of intravenous drug use and antiretroviral therapy. This study was cond
## Abstract Data on the effects of the presence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients co‐infected with these viruses and HIV in West Africa are conflicting and little information is available in Ghana. A cohort of 138 treatment naïve individuals infected with HIV was sc